Document Detail


Mechanism, temporal patterns, and magnitudes of the metabolic responses to the KATP channel agonist diazoxide.
MedLine Citation:
PMID:  15339745     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To assess the mechanism, temporal patterns, and magnitudes of the metabolic responses to the ATP-dependent potassium channel agonist diazoxide, neuroendocrine and metabolic responses to intravenous diazoxide (saline, 1.0 and 2.0 mg/kg) and oral diazoxide (placebo, 4.0 and 6.0 mg/kg) were assessed in healthy young adults. Intravenous diazoxide produced rapid, but transient, decrements (P = 0.0023) in plasma insulin (e.g., nadirs of 2.8 +/- 0.5 and 1.8 +/- 0.3 microU/ml compared with 7.0 +/- 1.0 microU/ml after saline at 4.0-7.5 min) and C-peptide (P = 0.0228) associated with dose-related increments in plasma glucose (P = 0.0044) and serum nonesterified fatty acids (P < 0.0001). After oral diazoxide, plasma insulin appeared to decline, as did C-peptide, again associated with dose-related increments in plasma glucose (P < 0.0001) and serum nonesterified fatty acids (P = 0.0141). Plasma glucagon, as well as cortisol and growth hormone, was not altered. Plasma epinephrine increased (P = 0.0215) slightly only after intravenous diazoxide. There were dose-related increments in plasma norepinephrine (P = 0.0038 and P = 0.0005, respectively), undoubtedly reflecting a compensatory sympathetic neural response to vasodilation produced by diazoxide, but these would not raise plasma glucose or serum nonesterified fatty acid levels. Thus selective suppression of insulin secretion, without stimulation of glucagon secretion, raised plasma glucose and serum nonesterified fatty acid concentrations. These findings define the temporal patterns and magnitudes of the metabolic responses to diazoxide and underscore the primacy of regulated insulin secretion in the physiological regulation of postabsorptive carbohydrate and lipid metabolism.
Authors:
Bharathi Raju; Philip E Cryer
Related Documents :
3039255 - A glucagon-secreting pancreatic alpha islet cell tumor presenting as spinal cord compre...
1173985 - A comparative study of serum growth hormone and plasma cortisol levels in stimulation t...
18843505 - Contribution of the blood glucose level in perinatal asphyxia.
7819685 - Inter-relationship between serum concentrations of glucose, glucagon and insulin during...
4212955 - Assay of rifampicin in serum.
6970715 - Pizpratt: a new alpha 1-antitrypsin allele in an american negro family.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.     Date:  2004-08-31
Journal Detail:
Title:  American journal of physiology. Endocrinology and metabolism     Volume:  288     ISSN:  0193-1849     ISO Abbreviation:  Am. J. Physiol. Endocrinol. Metab.     Publication Date:  2005 Jan 
Date Detail:
Created Date:  2004-12-08     Completed Date:  2005-03-02     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  100901226     Medline TA:  Am J Physiol Endocrinol Metab     Country:  United States    
Other Details:
Languages:  eng     Pagination:  E80-5     Citation Subset:  IM    
Affiliation:
Division of Endocrinology, Metabolism, and Lipid Research, The General Clinical Research Center, Washington University School of Medicine, St. Louis, Missouri, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adenosine Triphosphate / metabolism
Administration, Oral
Adult
Blood Glucose / drug effects,  metabolism
Diazoxide / administration & dosage*
Epinephrine / blood
Fatty Acids, Nonesterified / blood
Female
Glucagon / blood,  secretion
Humans
Injections, Intravenous
Insulin / blood,  secretion*
Male
Potassium Channels / agonists*,  physiology
Vasodilator Agents / administration & dosage*
Grant Support
ID/Acronym/Agency:
M01 RR-00036/RR/NCRR NIH HHS; P60 DK-20579/DK/NIDDK NIH HHS; R37 DK-27085/DK/NIDDK NIH HHS
Chemical
Reg. No./Substance:
0/Blood Glucose; 0/Fatty Acids, Nonesterified; 0/Potassium Channels; 0/Vasodilator Agents; 11061-68-0/Insulin; 364-98-7/Diazoxide; 51-43-4/Epinephrine; 56-65-5/Adenosine Triphosphate; 9007-92-5/Glucagon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Evidence against a role for insulin-signaling proteins PI 3-kinase and Akt in insulin resistance in ...
Next Document:  Time course of the hepatic adaptation to TPN: interaction with glycogen depletion.